Essential Fatty Acid Status & Immune Function in Parenteral Nutrition Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01986153|
Recruitment Status : Completed
First Posted : November 18, 2013
Last Update Posted : November 13, 2014
|Condition or disease|
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||60 participants|
|Target Follow-Up Duration:||1 Day|
|Official Title:||Essential Fatty Acid Status & Immune Function in Parenteral Nutrition Patients|
|Study Start Date :||December 2013|
|Actual Primary Completion Date :||November 2014|
|Actual Study Completion Date :||November 2014|
Home parenteral nutrition patients
Patients who receive home parenteral nutrition.
Those who don't receive home parenteral nutrition and consume a normal diet.
- Essential fatty acid status of plasma phospholipids and peripheral blood mononuclear cells, including the biochemical determination of the Holman index (ratio of mead acid/ arachidonic acid) [ Time Frame: On day of blood withdrawal ]
- Physical examination of clinical signs/symptoms of essential fatty acid deficiency [ Time Frame: On day of blood withdrawal ]
- Immune function: expression of cell surface markers, stimulus-induced reactive oxygen species production, cytokine production by leukocytes [ Time Frame: On day of blood withdrawal ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01986153
|Department of Gastroenterology and Hepatology|
|Nijmegen, Netherlands, 6525 GA|